Table of Content

1 Study Coverage
1.1 Oncology Injection Drug Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Injection Drug Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Oncology Injection Drug Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Oncology Injection Drug Market by Region
1.4.1 Global Oncology Injection Drug Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Oncology Injection Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Oncology Injection Drug Revenue by Players
2.1.1 Global Oncology Injection Drug Revenue by Players (2018-2023)
2.1.2 Global Oncology Injection Drug Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Oncology Injection Drug Revenue in 2023
2.2 Global Oncology Injection Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Oncology Injection Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Taj Oncology
3.1.1 Taj Oncology Information
3.1.2 Taj Oncology Overview
3.1.3 Taj Oncology Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.1.4 Taj Oncology Related Developments
3.2 S.G. Biopharm
3.2.1 S.G. Biopharm Information
3.2.2 S.G. Biopharm Overview
3.2.3 S.G. Biopharm Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.2.4 S.G. Biopharm Related Developments
3.3 AdvaCare
3.3.1 AdvaCare Information
3.3.2 AdvaCare Overview
3.3.3 AdvaCare Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.3.4 AdvaCare Related Developments
3.4 Merrimack
3.4.1 Merrimack Information
3.4.2 Merrimack Overview
3.4.3 Merrimack Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.4.4 Merrimack Related Developments
3.5 Celgene
3.5.1 Celgene Information
3.5.2 Celgene Overview
3.5.3 Celgene Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.5.4 Celgene Related Developments
3.6 Allos Therapeutics
3.6.1 Allos Therapeutics Information
3.6.2 Allos Therapeutics Overview
3.6.3 Allos Therapeutics Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.6.4 Allos Therapeutics Related Developments
3.7 Ferring Pharmaceuticals
3.7.1 Ferring Pharmaceuticals Information
3.7.2 Ferring Pharmaceuticals Overview
3.7.3 Ferring Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.7.4 Ferring Pharmaceuticals Related Developments
3.8 Genzyme
3.8.1 Genzyme Information
3.8.2 Genzyme Overview
3.8.3 Genzyme Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.8.4 Genzyme Related Developments
3.9 Eli Lilly
3.9.1 Eli Lilly Information
3.9.2 Eli Lilly Overview
3.9.3 Eli Lilly Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.9.4 Eli Lilly Related Developments
3.10 Praecis Pharmaceuticals
3.10.1 Praecis Pharmaceuticals Information
3.10.2 Praecis Pharmaceuticals Overview
3.10.3 Praecis Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.10.4 Praecis Pharmaceuticals Related Developments
3.11 Millennium Pharmaceuticals
3.11.1 Millennium Pharmaceuticals Information
3.11.2 Millennium Pharmaceuticals Overview
3.11.3 Millennium Pharmaceuticals Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.11.4 Millennium Pharmaceuticals Related Developments
3.12 Debiopharm
3.12.1 Debiopharm Information
3.12.2 Debiopharm Overview
3.12.3 Debiopharm Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.12.4 Debiopharm Related Developments
3.13 Alza
3.13.1 Alza Information
3.13.2 Alza Overview
3.13.3 Alza Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.13.4 Alza Related Developments
3.14 CordenPharma
3.14.1 CordenPharma Information
3.14.2 CordenPharma Overview
3.14.3 CordenPharma Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.14.4 CordenPharma Related Developments
3.15 Pharmascience
3.15.1 Pharmascience Information
3.15.2 Pharmascience Overview
3.15.3 Pharmascience Oncology Injection Drug Revenue and Gross Margin (2018-2023)
3.15.4 Pharmascience Related Developments
4 Global Oncology Injection Drug Market Insights
4.1 Global Oncology Injection Drug Market Revenue 2018-2023
4.2 Global Oncology Injection Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Oncology Injection Drug Revenue by Type
5.2 Global Oncology Injection Drug Market Size Growth by Type 2018-2023
6 Market Size by Application
6.1 Global Oncology Injection Drug Revenue by Application
6.2 Global Oncology Injection Drug Market Size Growth by Application 2018-2023
7 Americas
7.1 Americas Oncology Injection Drug Market Size by Type
7.1.1 Americas Oncology Injection Drug Revenue by Type (2018-2023)
7.1.2 Americas Oncology Injection Drug Revenue Share by Type (2018-2023)
7.2 Americas Oncology Injection Drug Market Size by Application
7.2.1 Americas Oncology Injection Drug Revenue by Application (2018-2023)
7.2.2 Americas Oncology Injection Drug Revenue Share by Application (2018-2023)
7.3 Americas Oncology Injection Drug Market Size by Country
7.3.1 Americas Oncology Injection Drug Revenue by Country (2018-2023)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Oncology Injection Drug Market Size by Type
8.1.1 Europe Oncology Injection Drug Revenue by Type (2018-2023)
8.1.2 Europe Oncology Injection Drug Revenue Share by Type (2018-2023)
8.2 Europe Oncology Injection Drug Market Size by Application
8.2.1 Europe Oncology Injection Drug Revenue by Application (2018-2023)
8.2.2 Europe Oncology Injection Drug Revenue Share by Application (2018-2023)
8.3 Europe Oncology Injection Drug Market Size by Country
8.3.1 Europe Oncology Injection Drug Revenue by Country (2018-2023)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Oncology Injection Drug Market Size by Type
9.1.1 Asia Pacific Oncology Injection Drug Revenue by Type (2018-2023)
9.1.2 Asia Pacific Oncology Injection Drug Revenue Share by Type (2018-2023)
9.2 Asia Pacific Oncology Injection Drug Market Size by Application
9.2.1 Asia Pacific Oncology Injection Drug Revenue by Application (2018-2023)
9.2.2 Asia Pacific Oncology Injection Drug Revenue Share by Application (2018-2023)
9.3 Asia Pacific Oncology Injection Drug Market Size by Region
9.3.1 Asia Pacific Oncology Injection Drug Revenue by Region (2018-2023)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Oncology Injection Drug Market Size by Type
10.1.1 Middle East and Africa Oncology Injection Drug Revenue by Type (2018-2023)
10.1.2 Middle East and Africa Oncology Injection Drug Revenue Share by Type (2018-2023)
10.2 Middle East and Africa Oncology Injection Drug Market Size by Application
10.2.1 Middle East and Africa Oncology Injection Drug Revenue by Application (2018-2023)
10.2.2 Middle East and Africa Oncology Injection Drug Revenue Share by Application (2018-2023)
10.3 Middle East and Africa Oncology Injection Drug Market Size by Country
10.3.1 Middle East and Africa Oncology Injection Drug Revenue by Country (2018-2023)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Oncology Injection Drug Industry Trends
11.2 Oncology Injection Drug Market Drivers
11.3 Oncology Injection Drug Market Challenges
11.4 Oncology Injection Drug Market Restraints
12 Oncology Injection Drug Forecasted Market Size by Type
12.1 Global Oncology Injection Drug Forecasted Revenue by Type
12.2 Global Oncology Injection Drug Forecasted Market Size Growth by Type 2023-2029
13 Oncology Injection Drug Forecasted Market Size by Application
13.1 Global Oncology Injection Drug Forecasted Revenue by Application
13.2 Global Oncology Injection Drug Forecasted Market Size Growth by Application 2023-2029
14 Global Oncology Injection Drug Market Forecasts
14.1 Global Oncology Injection Drug Market Revenue Forecasts 2023-2029
14.2 Global Oncology Injection Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Oncology Injection Drug Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Oncology Injection Drug Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Oncology Injection Drug Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Oncology Injection Drug Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer